Share
Share today's newsletter with a colleague and get credit if they sign up for SmartBrief.
Referral Count:
 
0

Story being shared
Sirtex, SingHealth to explore nanoparticles in treating cancer
Sirtex Medical and SingHealth have entered a deal to develop the use of carbon-cage nanoparticles in treating cancer. The technology is based on Technegas, which is used in nuclear medicine as an inhalable aerosol of carbon-cage nanoparticles for detecting blood clots in the lungs. The first research initiative under the partnership will explore the technology as a treatment for advanced ovarian cancer that has metastasized in the abdomen and pelvic region.

Or we can send an email on your behalf
You must submit valid email addresses only. Use of email addresses is subject to terms of SmartBrief's privacy policy .